Adapthealth Corp
NASDAQ:AHCO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.64
11.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Adapthealth Corp
Wall Street
Price Targets
AHCO Price Targets Summary
Adapthealth Corp
According to Wall Street analysts, the average 1-year price target for
AHCO
is 11.62 USD
with a low forecast of 9.09 USD and a high forecast of 14.7 USD.
AHCO Last Price Targets
Adapthealth Corp
The latest public price target was made on Nov 15, 2024 by
David MacDonald
from
Truist Financial
,
who expects
AHCO
stock to
rise by 19%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
David MacDonald
Truist Financial
|
12
USD
Upside 19% |
1 month ago
Nov 15, 2024
|
AdaptHealth (AHCO) PT Lowered to $12 at Truist Securities
StreetInsider
|
Eric Coldwell
Robert W. Baird
|
14
USD
Upside 39% |
2 months ago
Nov 6, 2024
|
AdaptHealth (AHCO) PT Lowered to $14 at Baird
StreetInsider
|
|
Eric Coldwell
Robert W. Baird
|
16
USD
Upside 58% |
3 months ago
Sep 23, 2024
|
Baird Reiterates Outperform Rating on AdaptHealth (AHCO)
StreetInsider
|
Kevin Caliendo
UBS
|
13
USD
Upside 29% |
5 months ago
Aug 8, 2024
|
UBS Reiterates Buy Rating on AdaptHealth (AHCO)
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AHCO's stock price target?
Price Target
11.62
USD
According to Wall Street analysts, the average 1-year price target for
AHCO
is 11.62 USD
with a low forecast of 9.09 USD and a high forecast of 14.7 USD.
What is Adapthealth Corp's Revenue forecast?
Projected CAGR
4%
The
compound annual growth rate
of Adapthealth Corp's revenue for the next 3 years is
4%.
What is Adapthealth Corp's Operating Income forecast?
Projected CAGR
9%
The
compound annual growth rate
of Adapthealth Corp's operating income for the next 3 years is
9%.
You don't have any saved screeners yet
